drugset / Trial / NCT05834062
Phentermine/Topiramate as Preventive Pharmacotherapy for Obesity
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will test the use of phentermine and topiramate compared with placebo in helping adolescents who are at high risk for developing obesity to lose weight
Timeline
- Start
- 2023-10-17
- Primary completion
- 2026-08
- Completion
- 2027-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Phentermine | Small molecule | 7.5 mg | Oral |
| Subject | Topiramate | Small molecule | 46 mg | Oral |
Indications
No indication recorded.